Delivery Order SPE2DB20D3101-SPE2DB22FK5V3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,550,071 units of Rocuronium 100 mg/10 ml vials. The $1,231.45 fixed-price contract has an ultimate completion date of August 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant provider of critical medical commodities to various federal...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Rocuronium 50 mg/5 ml vials. The $1,374.24 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,377,731 units of the drug Rocuronium 100 mg/10 ml vial (10 ml). The firm-fixed-price delivery order, valued at $1,128.03, has an ultimate completion date of August 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.66 firm fixed-price delivery order is for the supply of 4,566,133,818 units of Rocuronium 50 mg/5 ml vial, a critical medical product used in healthcare settings. The award is not designated with a set-aside and represents an open competition. It is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the delivery of Rocuronium 50 mg/5 ml vials to the Defense Logistics Agency (DLA). The $2,179.80 firm-fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through March 13, 2024 and was not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,565,704,171 units of the drug Rocuronium 50 mg/5 ml vial. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $1,813.95. The contract has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 mg/10 mL vials of the drug Rocuronium. The contract has a ceiling value of $1,105.56 and a completion date of June 25, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rocuronium 100 mg/10 ml vials on September 3, 2025. This non-set-aside, competitively awarded contract carries a ceiling value of $1,166.98 under a firm fixed-price arrangement, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of 4565030949 - ROCURONIUM 100 MG/10 ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,187.40 and an ultimate completion date of July 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4566842965 ROCURONIUM 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,980.18 and a period of performance through January 7, 2025. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FK5V3Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,558,029,625 units of the drug Rocuronium 50 mg/5 ml vial with a 5 ml volume. The $1,097.76 firm fixed price delivery order has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award did not utilize any set-aside designations, indicating open competition. No other major subcontractors were identified in the provided information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/8/22 |